HomeAKUMS • NSE
add
Akums Drugs and Pharmaceuticals Ltd
Previous close
₹569.35
Day range
₹555.00 - ₹578.50
Year range
₹405.00 - ₹1,175.90
Market cap
88.19B INR
Avg Volume
251.49K
P/E ratio
25.49
Dividend yield
-
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 10.56B | 11.79% |
Operating expense | 3.63B | 13.07% |
Net income | 1.48B | 457.25% |
Net profit margin | 13.98 | 419.18% |
Earnings per share | 9.10 | — |
EBITDA | 922.78M | 11.41% |
Effective tax rate | -99.11% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.76B | 108.07% |
Total assets | 41.13B | 16.98% |
Total liabilities | 10.50B | -62.45% |
Total equity | 30.64B | — |
Shares outstanding | 153.13M | — |
Price to book | 2.86 | — |
Return on assets | — | — |
Return on capital | 4.13% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.48B | 457.25% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024. Wikipedia
Founded
2004
Website
Employees
7,388
